Resources

Filter
Blogs
Case Studies
Data
Factsheets
Govt. Strategies, Plans, and Documents
High-Impact Practices
Infographics
Meeting Documents
Newsletters
Presentations
Publications
Q&A
Remarks
Toolkits
Videos and Webinars
Website and Portals
Advocacy & Awareness
Contraceptive Security
ECHO Study
Financing
Innovation
Policy and Enabling Environment
Rights
Service Delivery & Quality
Young People
Country
Commitment Maker
Country
Commitment Maker
Date: 04/11/2019
Source: WHO
Type: Publications
Providing clarity about the safety of hormonal contraceptive (HC) methods for women at risk of HIV and for women living with HIV (WLHIV) is a public health priority. The World Health Organization (WHO) publishes the medical eligibility criteria for contraceptive use (MEC). The MEC is an evidencebased guideline informed by a continuous review of evidence that provides recommendations on the safety...
Date: 04/10/2019
Source: Population Foundation of India
Type: Publications
India is one of the few countries, which officially adopted a national Family Planning Programme in 1952. The country has made significant progress since, with the decadal population growth reducing from 24% to in 1991 to 18% in 2011 and reductions in total fertitility rate from 3.4 in 1992-93 to 2.2 in 2015-2016. However, owing to high growth rates in the previous decades, the overall population...
Date: 04/03/2019
Source: FP2020
Type: Videos and Webinars
The purpose of the series of opportunity briefs developed by Track20 are to aid in prioritisation. There are multiple interventions that countries may invest in but choosing the right interventions starts with the data. The briefs are drawn from country specific data using DHS surveys to answer questions about the extent to which there are opportunities to grow mCPR within a country context....
Date: 04/03/2019
Source: FP2020
Type: Case Studies , Videos and Webinars
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label, randomized, clinical trial comparing three highly effective, reversible methods of contraception — the progestogen-only injectable depot-medroxyprogesterone acetate (DMPA), a levonorgestrel implant, and the non-hormonal copper intrauterine device — to evaluate whether there is any difference in the risk of...
Date: 04/02/2019
Source: WHO
Type: Case Studies
Results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study that compares the risks of HIV acquisition between women randomised to DMPA-IM, levonorgestrel (LNG) implant, or copper-releasing IUD, are expected to be published in mid-July 2019. Once the results are published, WHO will rapidly convene a Guideline Development Group to review the evidence and to update, as needed...
Can we help you find something?
Advocacy & Awareness
Contraceptive Security
ECHO Study
Financing
Innovation
Policy and Enabling Environment
Rights
Service Delivery & Quality
Young People
Country
Commitment Maker
Country
Commitment Maker